AQST - Aquestive Therapeutics a new overweight at Piper on oral film products
2024-04-11 14:48:40 ET
More on Aquestive Therapeutics
- Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024
- Aquestive Therapeutics, Inc. (AQST) Q4 2023 Earnings Call Transcript
- Aquestive Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Piper starts Aquestive at overweight, cites allergy reaction treatment
- Aquestive Therapeutics slumps 13%, prices $75M offering